**3. Summary**

Antiplatelet treatment with a single agent regimen is useful for Moyamoya patients with cerebral ischemia. There is no role of neither anticoagulant nor thrombolytic therapy in Moyamoya disease. Moyamoya patients with hypertension should get antihypertensive treatment. Experts do not recommend routinely prescribing antihypertensive drugs in Moyamoya disease without hypertension. Moyamoya patients with dyslipidemia may gain benefit from lipid-lowering therapy.

*Medical Management in Moyamoya Disease DOI: http://dx.doi.org/10.5772/intechopen.95775*
